Acasti Pharma (ACST) Soars: Stock Adds 10.0% in Session - Tale of the Tape 9:18 a.m. June 16, 2014 - Zacks.com
Activist Trying To Unlock A Potential 65% Upside In Neptune 8:57 a.m. April 15, 2014 - Seeking Alpha
Acasti Pharma: An Undervalued Biotech With A Potential Best-In-Class Omega-3 Drug 8:27 a.m. April 1, 2014 - Seeking Alpha
Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High 11:00 a.m. Feb. 21, 2014 - Seeking Alpha
3 Pharmaceutical Stocks to Sell Now 6:15 a.m. Jan. 31, 2014 - InvestorPlace.com
While Amarin Continues To Go Rancid, Neptune Will Soar 9:34 a.m. Jan. 11, 2014 - Seeking Alpha
Acasti Pharma: 7 Different Insiders Have Purchased Shares This Month 6:01 p.m. Dec. 10, 2013 - Seeking Alpha
Acasti Pharma: Increasing Investor Interest And Volatility Likely Cometh 2:28 p.m. July 9, 2013 - Seeking Alpha
Small-Cap Biotechs With Blockbuster Potential: Hugh Cleland 5:10 a.m. July 9, 2013 - Seeking Alpha
5 'Red Hot' Biotechs: Chen Lin 5:38 p.m. July 3, 2013 - Seeking Alpha
Five 'Red Hot' Biotechs: Chen Lin 5:38 p.m. July 3, 2013 - Seeking Alpha
Krill Oil's Omega-3s And CaPre: Brought To You By Acasti 3:58 a.m. April 3, 2013 - Seeking Alpha
3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part III 11:36 a.m. March 26, 2013 - Seeking Alpha
Amarin: The More You Know The Fishier It Gets 1:59 a.m. Feb. 27, 2013 - Seeking Alpha
3 Speculative Healthcare Companies With High Levels Of Insider Ownership 8:19 a.m. Feb. 19, 2013 - Seeking Alpha
Speculative Quasi-Biotech Neptune Off To A Strong Start In 2013 7:29 p.m. Jan. 29, 2013 - Seeking Alpha
Anything For A Buck: Jim Letourneau Looks To Canadian Biotech For Opportunity 1:37 p.m. Jan. 18, 2013 - Seeking Alpha
Acasti Reports Results of Annual and Special Meeting 9:45 a.m. Today - GlobeNewswire
Acasti Announces Resignation of Chief Financial Officer 7:01 a.m. June 16, 2014 - GlobeNewswire
Neptune, Acasti and NeuroBioPharm Announce Litigation Regarding its Former Chief Executive Officer 8:03 a.m. May 30, 2014 - Marketwire
Neptune, Acasti and NeuroBioPharm Announce Appointment of Interim CEO 8:01 a.m. May 23, 2014 - GlobeNewswire
Acasti Announces Fourth Quarter and Fiscal Year Results 5:31 p.m. May 21, 2014 - GlobeNewswire
Acasti to Present at Two Scientific Forums 8:31 a.m. May 1, 2014 - GlobeNewswire
Neptune, Acasti and NeuroBioPharm Announce Resignation of Chief Executive Officer 8:02 a.m. April 28, 2014 - GlobeNewswire
Neptune and Enzymotec Conclude Final Patent Infringement Settlement ad License Agreement 8:34 p.m. April 27, 2014 - GlobeNewswire
Neptune & Acasti Give Update on Patent Litigations With Enzymotec 2:25 p.m. April 1, 2014 - GlobeNewswire
Neptune and Acasti Provide Update on Patent Litigations With Enzymotec 10:53 a.m. Feb. 14, 2014 - GlobeNewswire
Acasti and Neptune Provide Update on Patent Litigations with Enzymotec 10:41 a.m. Feb. 14, 2014 - GlobeNewswire
Acasti Announces Closing of CAD$2.15 Million Private Placement 9:00 a.m. Feb. 7, 2014 - GlobeNewswire
Acasti Announces Third Quarter Results 8:30 a.m. Jan. 14, 2014 - GlobeNewswire
FDA Clears Acasti's Investigational New Drug Submission to Conduct PK Trial 8:30 a.m. Jan. 9, 2014 - GlobeNewswire
Acasti Appoints Jerald J. Wenker as Special Advisor and Nominee to Its Board of Directors 8:30 a.m. Dec. 19, 2013 - GlobeNewswire
Neptune, Acasti and Enzymotec Sign Settlement Term Sheet Resulting in Stay of ITC Investigation for 30 Days 9:59 a.m. Dec. 18, 2013 - GlobeNewswire
Neptune, Acasti and Enzymotec Sign Settlement Term Sheet Resulting in Stay of ITC Investigation for 30 Days 9:59 a.m. Dec. 18, 2013 - GlobeNewswire
Neptune and Aker BioMarine Reach Patent Infringement Settlement and License Agreement 9:31 a.m. Dec. 17, 2013 - GlobeNewswire
Neptune and Aker BioMarine Reach Patent Infringement Settlement and License Agreement 9:30 a.m. Dec. 17, 2013 - GlobeNewswire
Neptune Participates in the Equity Financing of Acasti Pharma 4:14 p.m. Dec. 3, 2013 - GlobeNewswire